Home » Topics » Regulatory » Patents

Patents
RSS

New indication claimed for EPO

Sep. 20, 1996

NPY antagonists from Glaxo Wellcome

Sep. 20, 1996

Pierre Fabre investigates ACAT inhibitors

Sep. 20, 1996

Wakamoto claims diclofenac eyedrop formulation

Sep. 20, 1996

Pfizer describes anticancer application for known antidepressant

Sep. 20, 1996

Novel anticancer tyrosine kinase inhibitors from Pharmacia & Upjohn

Sep. 20, 1996

HEK4-binding protein from Amgen

Sep. 20, 1996

RPR reports novel protein farnesyltransferase inhibitors

Sep. 20, 1996

CI-958 for treatment of prostate cancer

Sep. 20, 1996

SAMDC inhibitors from Ciba-Geigy

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...